Treace Medical Concepts I... (TMCI)
undefined
undefined%
At close: undefined
7.90
-0.25%
After-hours Jan 03, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 187.12M 141.84M 94.42M 57.37M 39.42M
Cost of Revenue 35.18M 27.52M 17.83M 12.47M 7.63M
Gross Profit 151.94M 114.31M 76.59M 44.90M 31.79M
Operating Income -51.43M -34.84M -16.51M -891.00K -3.54M
Interest Income 6.73M 910.00K 18.00K 2.78M 111.00K
Pretax Income -49.53M -42.81M -20.55M -3.67M -4.26M
Net Income -49.53M -47.30M -24.61M -6.45M -5.11M
Selling & General & Admin 187.93M 135.57M 82.90M 38.19M 30.25M
Research & Development 15.44M 13.58M 10.20M 5.85M 5.07M
Other Expenses n/a -403.00K 1K n/a n/a
Operating Expenses 203.37M 149.16M 93.10M 44.04M 35.32M
Interest Expense 5.17M 4.40M 4.06M 2.78M 841.00K
Selling & Marketing Expenses 140.89M 102.58M 64.47M 31.65M 25.79M
Cost & Expenses 238.55M 176.68M 110.93M 56.51M 42.95M
Income Tax n/a 4.48M 4.06M 2.78M 841.00K
Shares Outstanding (Basic) 60.85M 55.28M 54.18M 51.17M 51.17M
Shares Outstanding (Diluted) 60.85M 55.28M 54.18M 51.17M 51.17M
EPS (Basic) -0.81 -0.86 -0.45 -0.13 -0.1
EPS (Diluted) -0.81 -0.86 -0.45 -0.13 -0.1
EBITDA -39.01M -34.84M -15.81M 2.06M -2.63M
Depreciation & Amortization 5.35M 4.66M 685.00K 1.21M 793.00K